These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 11349809)

  • 1. Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation.
    Ho VT; Weller E; Lee SJ; Alyea EP; Antin JH; Soiffer RJ
    Biol Blood Marrow Transplant; 2001; 7(4):223-9. PubMed ID: 11349809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity.
    Gopal R; Ha CS; Tucker SL; Khouri IF; Giralt SA; Gajewski JL; Andersson BS; Cox JD; Champlin RE
    Cancer; 2001 Oct; 92(7):1949-58. PubMed ID: 11745270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse alveolar hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: related and high-risk clinical syndromes.
    Majhail NS; Parks K; Defor TE; Weisdorf DJ
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1038-46. PubMed ID: 17067910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation.
    Savani BN; Montero A; Srinivasan R; Singh A; Shenoy A; Mielke S; Rezvani K; Karimpour S; Childs R; Barrett AJ
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1261-9. PubMed ID: 17162207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary review.
    Elliott MA; Nichols WL; Plumhoff EA; Ansell SM; Dispenzieri A; Gastineau DA; Gertz MA; Inwards DJ; Lacy MQ; Micallef IN; Tefferi A; Litzow M
    Mayo Clin Proc; 2003 Apr; 78(4):421-30. PubMed ID: 12683694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term complications of total body irradiation in adults.
    Thomas O; Mahé M; Campion L; Bourdin S; Milpied N; Brunet G; Lisbona A; Le Mevel A; Moreau P; Harousseau J; Cuillière J
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):125-31. PubMed ID: 11163505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics.
    Keklik F; Alrawi EB; Cao Q; Bejanyan N; Rashidi A; Lazaryan A; Arndt P; Dincer EH; Bachanova V; Warlick ED; MacMillan ML; Arora M; Miller J; Brunstein CG; Weisdorf DJ; Ustun C
    Haematologica; 2018 Dec; 103(12):2109-2115. PubMed ID: 30076172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.
    Koh LP; Chen CS; Tai BC; Hwang WY; Tan LK; Ng HY; Linn YC; Koh MB; Goh YT; Tan B; Lim S; Lee YM; Tan KW; Liu TC; Ng HJ; Loh YS; Mow BM; Tan DC; Tan PH
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):790-805. PubMed ID: 17580257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience.
    Piñana JL; Valcárcel D; Martino R; Barba P; Moreno E; Sureda A; Vega M; Delgado J; Briones J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):21-9. PubMed ID: 19135939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung function, pulmonary complications, and mortality after allogeneic blood and marrow transplantation in children.
    Kaya Z; Weiner DJ; Yilmaz D; Rowan J; Goyal RK
    Biol Blood Marrow Transplant; 2009 Jul; 15(7):817-26. PubMed ID: 19539213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease.
    van Burik JA; Carter SL; Freifeld AG; High KP; Godder KT; Papanicolaou GA; Mendizabal AM; Wagner JE; Yanovich S; Kernan NA
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1487-98. PubMed ID: 18022579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation.
    Savani BN; Montero A; Wu C; Nlonda N; Read E; Dunbar C; Childs R; Solomon S; Barrett AJ
    Biol Blood Marrow Transplant; 2005 Mar; 11(3):223-30. PubMed ID: 15744241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
    Aschan J; Ringdén O
    Clin Transplant; 1994 Jun; 8(3 Pt 1):258-70. PubMed ID: 8061365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy.
    Lewis ID; DeFor T; Weisdorf DJ
    Bone Marrow Transplant; 2000 Sep; 26(5):539-43. PubMed ID: 11019844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninfectious Pulmonary Toxicity after Allogeneic Hematopoietic Cell Transplantation.
    Patel SS; Ahn KW; Khanal M; Bupp C; Allbee-Johnson M; Majhail NS; Hamilton BK; Rotz SJ; Hashem H; Beitinjaneh A; Lazarus HM; Krem MM; Prestidge T; Bhatt NS; Sharma A; Gadalla SM; Murthy HS; Broglie L; Nishihori T; Freytes CO; Hildebrandt GC; Gergis U; Seo S; Wirk B; Pasquini MC; Savani BN; Sorror ML; Stadtmauer EA; Chhabra S
    Transplant Cell Ther; 2022 Jun; 28(6):310-320. PubMed ID: 35314376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
    Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
    Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
    Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine as possible prophylaxis for obstructive airways disease after allogeneic bone marrow transplantation.
    Payne L; Chan CK; Fyles G; Hyland RH; Bafundi P; Yeung M; Messner H
    Chest; 1993 Jul; 104(1):114-8. PubMed ID: 8325051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
    Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G
    Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.